Edition:
United Kingdom

Teligent Inc (TLGT.OQ)

TLGT.OQ on NASDAQ Stock Exchange Global Select Market

1.74USD
18 Jan 2019
Change (% chg)

$-0.04 (-2.25%)
Prev Close
$1.78
Open
$1.78
Day's High
$1.78
Day's Low
$1.74
Volume
32,209
Avg. Vol
82,841
52-wk High
$4.52
52-wk Low
$1.13

Latest Key Developments (Source: Significant Developments)

Teligent Inc Executes $120 Million Financing Agreement
Thursday, 13 Dec 2018 

Dec 13 (Reuters) - Teligent Inc ::TELIGENT- NEW SENIOR-SECURED ASSET-BASED FIRST LIEN REVOLVING CREDIT FACILITY, SECOND LIEN TERM LOANS ARE IN AGGREGATE PRINCIPAL AMOUNTS OF $25 MILLION AND UPTO $95 MILLION RESPECTIVELY (ADDS DROPPED WORDS).TELIGENT, INC. EXECUTES $120 MILLION FINANCING AGREEMENT.DECEMBER 13, 2018 COMPANY ENTERED INTO A DEFINITIVE FIRST LIEN REVOLVING CREDIT AGREEMENT WITH ACF FINCO I LP.$80 MILLION OF TERM LOANS TO BE USED TO REDEEM OR REPURCHASE IN PART THE CO'S 3.75% SENIOR NOTES MATURING IN DECEMBER 2019.  Full Article

Teligent Announces FDA Approval Of Desoximetasone Ointment USP 0.05%
Wednesday, 24 Oct 2018 

Oct 24 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF DESOXIMETASONE OINTMENT USP 0.05%.  Full Article

Teligent Inc Announces FDA Approval Of Fluocinonide Ointment Usp, 0.05%
Tuesday, 2 Oct 2018 

Oct 2 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF FLUOCINONIDE OINTMENT USP, 0.05%.TELIGENT INC - PLANNING TO LAUNCH FLUOCINONIDE OINTMENT USP, 0.05% IN Q4 OF 2018.  Full Article

Teligent Inc QTRLY Loss Per Share $0.39
Wednesday, 8 Aug 2018 

Teligent Inc ::TELIGENT, INC. ANNOUNCES SECOND QUARTER 2018 RESULTS.Q2 REVENUE FELL 9 PERCENT TO $16.8 MILLION.EXPANSION OF BUENA, NEW JERSEY MANUFACTURING FACILITY IS ON TRACK.QTRLY LOSS PER SHARE $0.39.  Full Article

Teligent Announces FDA Approval Of Lidocaine And Prilocaine Cream
Monday, 2 Jul 2018 

July 2 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF LIDOCAINE AND PRILOCAINE CREAM USP, 2.5%/2.5%.TELIGENT INC - PLAN TO LAUNCH LIDOCAINE AND PRILOCAINE CREAM USP, 2.5%/2.5% IN Q3 OF 2018.  Full Article

Teligent Announces FDA Approval Of Fluocinonide Gel
Wednesday, 20 Jun 2018 

June 20 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF FLUOCINONIDE GEL, 0.05%.TELIGENT INC - PLANNING TO LAUNCH FLUOCINONIDE GEL, 0.05% IN Q3 2018.  Full Article

Teligent Reports Q1 Loss Per Share $0.09
Tuesday, 8 May 2018 

May 8 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FIRST QUARTER 2018 RESULTS.TELIGENT INC <<>> Q1 REVENUE FELL 26 PCT TO $14.5 MLN.TELIGENT INC <<>>- QTRLY SHR LOSS $0.09.  Full Article

Prosight Management Reports A Passive Stake Of 6.8 Pct In Teligent
Monday, 7 May 2018 

May 7 (Reuters) - Teligent Inc ::PROSIGHT MANAGEMENT LP REPORTS A PASSIVE STAKE OF 6.8 PERCENT IN TELIGENT AS OF APRIL 27 - SEC FILING.  Full Article

Teligent Inc Announces FDA Approval Of Clobetasol Propionate Cream
Tuesday, 17 Apr 2018 

April 17 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF CLOBETASOL PROPIONATE CREAM USP, 0.05%.TELIGENT INC - RECEIVED APPROVAL OF CO'S ABBREVIATED NEW DRUG APPLICATION FROM U.S. FDA OF CLOBETASOL PROPIONATE CREAM USP, 0.05%.  Full Article

Teligent Appoints Damian Finio As Chief Financial Officer
Friday, 26 Jan 2018 

Jan 26 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES THE APPOINTMENT OF DAMIAN FINIO AS CHIEF FINANCIAL OFFICER.TELIGENT INC - FINIO WILL SUCCEED JENNIFFER COLLINS, WHO IS LEAVING CO TO PURSUE PERSONAL AND PROFESSIONAL OPPORTUNITIES.  Full Article